Dr. Hunger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Childrens Hospital Of Philadelphia
Philadelphia, PA 19104Phone+1 215-590-3535Fax+1 215-590-3992
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1988 - 1991
- Johns Hopkins UniversityResidency, Pediatrics, 1985 - 1988
- Uconn School Of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1988 - Present
- FL State Medical License 2001 - Present
- PA State Medical License 2015 - 2024
- NY State Medical License 2015 - 2023
- CO State Medical License 1994 - 2015
- MD State Medical License 1987 - 1988
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia Start of enrollment: 1999 Apr 01
- Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia Start of enrollment: 2006 May 01
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2006 Sep 25
Publications & Presentations
PubMed
- 58 citationsA framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC)...Scott C. Howard, Alan Davidson, Sandra Luna-Fineman, Trijn Israels, Guillermo Chantada
Pediatric Blood & Cancer. 2017-12-01 - 71 citationsTreatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal.Stephen P. Hunger, Lillian Sung, Scott C. Howard
Pediatric Blood & Cancer. 2009-05-01 - 33 citationsPRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.Ingrid M. Ariës, Kimberly Bodaar, Salmaan Karim, Triona Ni Chonghaile, Laura Hinze
The Journal of Experimental Medicine. 2018-12-03
Journal Articles
- Targeting EIF4E Signaling with Ribavirin in Infant Acute Lymphoblastic LeukemiaNyla A Heerema, James W Davenport, Carolyn A Felix, Andrew J Carroll, ZoAnn E Dreyer, Alix E Seif, David T Teachey, Joanne M Hilden, Sarah K Tasian, Cheryl L Willman, ..., Nature
- Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology GroupMichael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood
- Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic LeukaemiaMichael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature
Abstracts/Posters
- Germline RUNX1 Variation and Predisposition to T-Cell Acute Lymphoblastic Leukemia in ChildrenStephen P. Hunger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell TherapyStephen P. Hunger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Identification of New Risk Loci and Regulatory Mechanisms Influencing Genetic Susceptibility to Acute Lymphoblastic LeukaemiaStephen P. Hunger, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Optimizing Clinical Outcomes in Blood Cancers Through Groundbreaking Translational Research61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clini...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Children's Hospital of Philadelphia Names Chief of Hematologic MalignanciesJuly 13th, 2021
- Children’s Hospital of Philadelphia Appoints Leukemia Specialist as Section ChiefJuly 11th, 2021
- Long-Term Repercussions of Postponing Care Due to COVID-19March 8th, 2021
- Join now to see all
Grant Support
- Post Graduate Training In Pediatric OncologyNational Cancer Institute2011
- Molecular Signatures For Outcome Prediction And Therapeutic Targeting In AllNational Cancer Institute2011
- Identifying The Spectrum Of Genetic Alterations In High Risk AllNational Cancer Institute2010
- Targeted Therapies For Childhood Acute Lymphoblastic LeukemiaNational Cancer Institute2009–2010
- Postgraduate Training In Pediatric OncologyNational Cancer Institute2008–2009
- Phase I Study Of Erbitux (CETUXIMAB) In Ped Subj With Solid Tumors Ca225-085National Center For Research Resources2007
- Anbl0032, Phase III Randomized Study Of Chimeric Anti-Gd2 In High Risk NeuroblaeNational Center For Research Resources2007
- A Multicenter Phase I Trial Of 17-N-Allylamino-17-Demethoxy GeldanamycinNational Center For Research Resources2006
- A Multicenter Phase I Trial Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-AsNational Center For Research Resources2005
- Measuring Asparagine Synthetase Expression In LeukemiaNational Cancer Institute2004–2005
- Functional Analysis Of The T(17--19)-All Chimera E2A-HLFNational Cancer Institute1998
- Molecular Analysis Of Chromosomal TranslocationsNational Cancer Institute1991–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: